Penny Coulson

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: October 03, 2025

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Nature communications

Published: September 22, 2025

Leveraging large language models for structured information extraction from pathology reports.

Leveraging large language models for structured information extraction from pathology reports.

Journal: Journal of pathology informatics

Published: February 04, 2025

Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.

Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: November 21, 2023

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 14, 2023

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.

Journal: The journal of pathology. Clinical research

Published: November 23, 2022

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Journal: Cancer

Published: June 17, 2022

Risk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatment.

Risk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatment.

Journal: Leukemia & lymphoma

Published: November 05, 2021

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: September 13, 2021

Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.

Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.

Journal: The Journal of pathology

Published: September 04, 2021

Risk of breast cancer in men in relation to weight change: A national case-control study in England and Wales.

Risk of breast cancer in men in relation to weight change: A national case-control study in England and Wales.

Journal: International journal of cancer

Published: July 14, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026